Latest filing published 23 Jun 2026 for GeneDx Holdings Corp..
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Richard C. Pfenniger Jr. across 10 companies, led by GP Strategies Corp, Opko Health, Inc. and Wright Investors Service Holdings, Inc. Over a trading history stretching from 2 February 2005 to 18 June 2026, the count stands at 153 filings.
The open-market record is one-sided, with 18 purchases worth €418k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 108 share grants and 23 option exercises.
The median purchase comes to €13k. 12 out of 17 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 23 June 2026, the filings show an option exercise in GeneDx Holdings Corp. The latest purchase dates back some time: it was published 1,022 days ago, on 5 January 2024. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations